Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Humanities

The new medical model: a renewed challenge for biomedicine

Jonathan Fuller
CMAJ May 01, 2017 189 (17) E640-E641; DOI: https://doi.org/10.1503/cmaj.160627
Jonathan Fuller
Research Fellow, The Wilson Centre, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Over the past 25 years, several new “medicines” have come screeching onto health care’s various platforms, including narrative medicine, personalized medicine, precision medicine and person-centred medicine. Philosopher Miriam Solomon calls the first three of these movements different “ways of knowing” or “methods,” and argues that they are each a response to shortcomings of methods that came before them.1 They should also be understood as reactions to the current dominant model of medicine. In this article, I will describe our dominant model, which I call “the new medical model.”2 I will argue that several towering problems in modern medicine can be traced to its philosophical foundations, which calls for philosophical analysis.

Forty years ago in his article “The Need for a New Medical Model: A Challenge for Biomedicine,”3 psychiatrist Dr. George Engel wrote: “The dominant model of disease today is biomedical.” Engel argued that the “biomedical model” or “biomedicine” was the traditional model of disease as well as the orthodox model of medical practice. This model conceptualized disease as deviation from normal biological functioning owing to biological determinants, described in the language of the basic biomedical sciences, including anatomy, physiology and molecular biology.

The biomedical model directed the physician to correct disease and restore normal functioning. How so? By using knowledge from these very sciences. Because of the perceived “reductionism” and neglect of the psychological and the social among the components of the model, the biomedical model has since been a target of incisive criticisms, many of which have been advanced by scholars in the humanities and social sciences, including philosophers.4

Although biomedicine is sometimes called “the medical model,” I will refer to it as the “old medical model” for reasons I will explain shortly. We can identify at least three essential components of the old medical model as described by Engel: a disease concept, an ethic and a logic. Its disease concept is disease-as-bodily-biological-dysfunction. Its ethic or ethical imperative is to cure the disease, fix the dysfunction. Finally, its logic or “style of scientific reasoning”5 consists of biomedical “mechanistic reasoning,” reasoning through biomedical mechanisms of health and disease. In summary, the kind of medicine modelled by the old medical model is one in which physicians cure biological disease using biomedical mechanistic reasoning. The paradigmatic diseases for the old model are acute infectious diseases, which are generally curable, and can be understood and treated using biologic rationale: for a bacterial infection, treat with an antibiotic to halt the germ’s growth or survival, and thus clear the infection.

By the time Engel wrote his “challenge to biomedicine,” health care was already being transformed by two major developments: the rise of chronic diseases and evidence-based medicine. Chronic diseases defy the old medical model because they are generally incurable, and many patients with chronic disease have not one disease but multiple distinct diseases (multimorbidity). Meanwhile, evidence-based medicine defies the old model by privileging reasoning from the results of clinical epidemiologic studies rather than mechanistic reasoning.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

A photograph of Physiological Manikin (life-size anatomy atlas), by James T. White, circa 1895. Archived at the University of Toronto Scientific Instruments Collection, Toronto, Ontario.

Image courtesy of Ari Gross and Erich Weidenhammer

In response to these new clinical realities, the old medical model has evolved into the “new medical model,” which represents the cure, prevention and management of biological disease(s) using the reasoning and principles of evidence-based medicine.2 The new medical model’s disease concept may be unchanged compared with the old model (the “concept of disease” debate in the philosophy of medicine is lively and ongoing6). However, the new model’s ethic is expanded to accommodate the prevention and management of incurable chronic disease and multimorbidity, and its logic is the logic of evidence-based medicine.

The new medical model is enshrined in clinical guideline–directed care because guidelines are typically disease-specific and evidence-based. For instance, the guideline-driven care of a patient with type 2 diabetes and heart failure would have the physician manage these biological disturbances (in glucose homeostasis, in cardiac function) individually while preventing other diseases or complications through interventions supported by evidence from clinical research, especially clinical trials.

The new medical model was not quite what Engel had in mind when he announced the need for a new model in the title of his seminal essay.3 The new medical model blends the old with the new, inheriting many of the advantages and disadvantages of the old model, while creating new problems for medicine. These problems include reductionistic and fractured care, as well as the challenges of generalizing and applying study results. These practical problems are entangled with philosophical problems, problems concerning the metaphysics or nature of chronic disease and multimorbidity, the ethical ends of medicine and the epistemology or logic of evidence-based medicine. Philosophers can be of service here by disentangling the philosophical from the practical problems and contributing toward unraveling both.

In the philosophy of medicine, reductionism can be understood as a strategy in which clinical symptoms or outcomes are explained with respect to parts of the patient (organs, cells, molecules).7 Similarly, in medicine, patient care is often described as reductionistic when it is oriented toward or organized around body parts instead of treating the whole patient in their life context. Together, the new medical model’s disease concept and its disease-centred ethic promote reductionism, because diseases are understood with reference to the body’s component parts, and the goal is to cure, prevent or manage the disease. When patients have multimorbidity, care can further become fractured or fragmented under the new model — with increased risk of treatment conflicts — because multimorbidity is managed by treating each of its constituent diseases.

Philosophers of medicine can lend insight into these problems by investigating our concept of disease,6 the nature of chronic disease and comorbidity/multimorbidity,8 and explanatory strategies in medicine.7 For example, given the importance of psychological and social factors in the prevention and management of chronic maladies, it is worthwhile exploring whether chronic diseases and their pathogenesis are best understood — and even best defined — at psychological and social levels in addition to biological levels. However, how can we define multilevel chronic diseases and pathogenesis in a substantive way that facilitates effective prevention and management and goes beyond simply listing social determinants?2 Likewise, because fractured care is so problematic, it is worth exploring whether comorbidities are truly distinct/discrete entities,2,8 and how we might better represent and classify complex morbidity in a more integrative way for patients who currently receive multiple chronic disease diagnoses.

Meanwhile, the challenges of generalizing and applying study results arise because of the evidence-based logic of the new medical model, in which physicians make diagnostic, prognostic and therapeutic predictions based on clinical epidemiologic evidence. Generalizing study results and applying them to particular patients are inferences and, like all scientific inferences, they rely upon assumptions.9 Unfortunately, the inferences and their assumptions are poorly articulated in medicine and rarely acknowledged. Medical commentators often worry that explanatory randomized trials have poor generalizability and average study results apply poorly to particular patients, if at all. Philosophers of science investigate such concerns by rationally reconstructing the underlying inferences, exposing and examining their assumptions, and by developing alternate methods for sound prediction.9,10

The practical challenges I described (reductionistic/fractured care, generalizing/applying study results) are not inevitable challenges for medicine, because they arise owing to the concepts, ethics and logic of a particular model of practice (the new medical model). Various recent movements in medicine seek to remedy the model’s shortcomings. Narrative medicine and person-centred medicine reject the model’s disease-centred ethic. Personalized medicine and precision medicine focus on its logic and aim to improve individualized prediction. Engel’s own strategy was to reject the medical model’s disease concept and propose a biopsychosocial model3 in which disease is conceptualized in terms of the psychological and social in addition to the biological.

In summary, the new medical model represents the evolution of biomedicine in response to the rise of chronic diseases and evidence-based medicine, and it embodies a philosophy of care on a grand scale. Rising to the new challenges that it poses will require both medical and philosophical wisdom.2

Footnotes

  • This article has been peer reviewed.

  • Funding: Jonathan Fuller received scholarship support from the Canadian Institutes of Health Research.

References

  1. ↵
    1. Solomon M
    . On ways of knowing in medicine. CMAJ 2016;188:289–90.
    OpenUrlFREE Full Text
  2. ↵
    1. Fuller J
    . The new medical model: chronic disease and evidence-based medicine [PhD dissertation]. University of Toronto; 2016.
  3. ↵
    1. Engel GL
    . The need for a new medical model: a challenge for biomedicine. Science 1977;196:129–36.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Marcum JA
    . Reflections on humanizing biomedicine. Perspect Biol Med 2008;51:392–405.
    OpenUrl
  5. ↵
    1. Hacking I
    . Language, truth and reason. In: Hollis M, Lukes S, editors. Rationality and relativism Cambridge (MA): MIT Press; 1982:48–66.
  6. ↵
    1. Boorse C
    . Concepts of health and disease. In: Gab-bay DM, Thagard P, Woods J, editors. Philosophy of medicine (Handbook of the philosophy of science: volume 16). Amsterdam: Elsevier; 2011:13–64.
  7. ↵
    1. De Vreese L,
    2. Weber E,
    3. Bouwel J
    . Explanatory pluralism in the medical sciences: theory and practice. Theor Med Bioeth 2010;31:371–90.
    OpenUrlPubMed
  8. ↵
    1. Upshur REG,
    2. Tracy S
    . Chronicity and complexity: Is what’s good for the diseases always good for the patients? Can Fam Physician 2008;54:1655–8.
    OpenUrlFREE Full Text
  9. ↵
    1. Fuller J,
    2. Flores LJ
    . The Risk GP Model: The standard model of prediction in medicine. Stud Hist Philo Biol Biomed Sci 2015;54:49–61.
    OpenUrl
  10. ↵
    1. Cartwright N
    . A philosopher’s view of the long road from RCTs to effectiveness. Lancet 2011; 377:1400–1.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (17)
CMAJ
Vol. 189, Issue 17
1 May 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The new medical model: a renewed challenge for biomedicine
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The new medical model: a renewed challenge for biomedicine
Jonathan Fuller
CMAJ May 2017, 189 (17) E640-E641; DOI: 10.1503/cmaj.160627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The new medical model: a renewed challenge for biomedicine
Jonathan Fuller
CMAJ May 2017, 189 (17) E640-E641; DOI: 10.1503/cmaj.160627
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • The new medical model: why medicine needs philosophy
  • The “new” medical model, fragmented clinical care and philosophy of medicine
  • PubMed
  • Google Scholar

Cited By...

  • La prescription sociale: Appel a laction
  • Social prescribing: A call to action
  • Preoperative bariatric surgery programme barriers facing Pacific patients in Auckland, New Zealand as perceived by health sector professionals: a qualitative study
  • Poverty as a medical condition
  • The "new" medical model, fragmented clinical care and philosophy of medicine
  • The new medical model: why medicine needs philosophy
  • Google Scholar

More in this TOC Section

  • “Patients deserve agency when it comes to their body”: a patient’s experience with endometriosis
  • Notes in still
  • Colonial tuberculosis legacies and the Dynevor Indian Hospital (1908–1934)
Show more Humanities

Similar Articles

Collections

  • Article Types
    • Medicine & Society

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire